| Issue |
Section |
Title |
File |
| Vol 6, No 2 (2016) |
ORIGINAL REPORTS |
Factors associated with the efficiency of maintenance therapy in patients with metastatic colorectal cancer |
(Rus)
|
| Vol 7, No 3 (2017) |
ORIGINAL REPORTS |
Effect of cancer drugs in patients with metastatic colorectal cancer in terms of mortality reduction |
(Rus)
|
| Vol 8, No 1 (2018) |
ORIGINAL REPORTS |
Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status |
(Rus)
|
| Vol 8, No 2 (2018) |
ORIGINAL REPORTS |
Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study |
(Rus)
|
| Vol 9, No 1 (2019) |
ORIGINAL REPORT |
Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study |
(Rus)
|
| Vol 9, No 4 (2019) |
ORIGINAL REPORT |
FOLFOXIRI in patients with colon cancer and isolated non-resectable liver metastases: phase II prospective non-randomized single-center study |
(Rus)
|
| Vol 11, No 3-4 (2021) |
ORIGINAL REPORT |
Efficacy and toxicity of aflibercept and bevacizumab in combination with FOLFIRI in second‑line therapy for metastatic colon cancer: a retrospective multicenter study |
(Rus)
|
